Free Trial

Bio-Path (BPTH) Short Interest Ratio & Short Volume

Bio-Path logo
$0.16 -0.02 (-8.82%)
As of 03/28/2025 03:59 PM Eastern

Bio-Path Short Interest Data

Bio-Path (BPTH) has a short interest of 463,100 shares, representing 8.03% of the float (the number of shares available for trading by the public). This marks a 483.25% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.2, indicating that it would take 0.2 days of the average trading volume of 1.61 million shares to cover all short positions.

Current Short Interest
463,100 shares
Previous Short Interest
79,400 shares
Change Vs. Previous Month
+483.25%
Dollar Volume Sold Short
$291,753.00
Short Interest Ratio
0.2 Days to Cover
Last Record Date
February 15, 2025
Outstanding Shares
8,308,000 shares
Float Size
5,770,000 shares
Short Percent of Float
8.03%
Today's Trading Volume
57,003 shares
Average Trading Volume
1,610,484 shares
Today's Volume Vs. Average
4%
Short Selling Bio-Path?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Bio-Path and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

BPTH Short Interest Over Time

BPTH Days to Cover Over Time

BPTH Percentage of Float Shorted Over Time

Remove Ads

Bio-Path Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
2/15/2025463,100 shares $291,753.00 +483.3%8.0%0.2 $0.63
1/31/202579,400 shares $64,107.56 -56.1%1.4%0 $0.81
1/15/2025181,000 shares $153,198.40 -27.6%3.1%0.1 $0.85
12/31/2024250,000 shares $290,000.00 +189.4%5.8%0.1 $1.16
12/15/202486,400 shares $57,127.68 +179.6%2.0%0 $0.66
11/30/202430,900 shares $23,793.00 -18.9%0.7%0 $0.77
11/15/202438,100 shares $30,956.25 -51.0%0.9%0 $0.81
10/31/202477,800 shares $70,447.90 -80.0%2.1%0.1 $0.91
10/15/2024388,600 shares $446,890.00 +3,947.9%10.5%0.3 $1.15
9/30/20249,600 shares $8,735.04 -41.5%0.4%0 $0.91
9/15/202416,400 shares $16,728.00 -64.4%0.6%0 $1.02
8/31/202446,100 shares $45,484.52 -16.6%1.8%0.1 $0.99
8/15/202455,300 shares $82,397.00 -9.6%2.2%0 $1.49
7/31/202461,200 shares $96,696.00 -45.0%2.9%0.1 $1.58
7/15/2024111,300 shares $213,696.00 -23.5%5.4%0.1 $1.92
6/30/2024145,400 shares $290,800.00 +76.0%7.0%0.1 $2.00
6/15/202482,600 shares $178,416.00 +159.8%4.0%0 $2.16
5/31/202431,800 shares $65,508.00 +32.5%2.0%0 $2.06
5/15/202424,000 shares $53,760.00 -46.0%1.5%0 $2.24
4/30/202444,400 shares $125,652.00 +62.0%2.9%0 $2.83
4/15/202427,400 shares $80,830.00 -59.4%3.6%0 $2.95
3/31/202467,400 shares $277,688.00 +6.3%9.0%2.7 $4.12
3/15/202463,400 shares $291,640.00 +284.2%9.6%3 $4.60
2/29/202416,500 shares $100,320.00 -14.5%2.7%1.7 $6.08
2/15/202419,300 shares $170,612.00 -94.9%3.1%2.9 $8.84
1/31/2024378,300 shares $162,669.00 -6.0%N/A3.5 $0.43
1/15/2024402,500 shares $201,250.00 +7.3%N/A1.7 $0.50
12/31/2023375,200 shares $173,717.60 -12.9%N/A0.1 $0.46
12/15/2023430,900 shares $202,523.00 -18.6%N/A0.2 $0.47
11/30/2023529,600 shares $296,576.00 -23.9%N/A0.2 $0.56
11/15/2023695,700 shares $371,225.52 -28.3%N/A0.3 $0.53
10/31/2023969,600 shares $639,451.20 +240.3%N/A0.4 $0.66
10/15/2023284,900 shares $213,675.00 +66.9%N/A0.1 $0.75
9/30/2023170,700 shares $63,159.00 -21.2%N/A0.5 $0.37
9/15/2023216,700 shares $88,847.00 +23.1%N/A0.6 $0.41
8/31/2023176,000 shares $72,652.80 -19.4%N/A0.5 $0.41
8/15/2023218,300 shares $82,735.70 -46.7%N/A0.7 $0.38
7/31/2023409,300 shares $433,858.00 +44.1%N/A1.4 $1.06
7/15/2023284,000 shares $369,200.00 +44.8%N/A6.9 $1.30
6/30/2023196,200 shares $349,236.00 +111.9%N/A5.8 $1.78
URGENT: Someone's Moving Gold Out of London... (Ad)

People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “gold analysts” have it all wrong… They tell you to invest in gold ETFs - because the popular mining ETFs will someday catch fire and close the price gap with spot gold.

Go here to learn about my Top Four picks for the coming bull mania.
6/15/202392,600 shares $152,780.74 +15.3%N/A2.8 $1.65
5/31/202380,300 shares $132,495.00 +7.5%N/A3 $1.65
5/15/202374,700 shares $112,050.00 +6.1%N/A2.5 $1.50
4/30/202370,400 shares $99,264.00 -15.8%N/A2.3 $1.41
4/15/202383,600 shares $116,195.64 +10.0%N/A2.4 $1.39
3/31/202376,000 shares $105,640.00 +18.6%N/A2.1 $1.39
3/15/202364,100 shares $96,150.00 -9.7%N/A1.7 $1.50
2/28/202371,000 shares $128,510.00 +59.2%N/A1.8 $1.81
2/15/202344,600 shares $88,018.10 +49.7%N/A1.1 $1.97
1/31/202329,800 shares $61,984.00 +122.4%N/A0.4 $2.08
1/15/202313,400 shares $23,986.00 -53.2%N/A0.2 $1.79
12/30/202228,600 shares $43,186.00 -21.6%N/A0.5 $1.51
12/15/202236,500 shares $54,385.00 +644.9%N/A0.6 $1.49
11/30/20224,900 shares $7,203.00 -84.9%N/A0.1 $1.47
11/15/202232,500 shares $49,725.00 -5.3%N/A0.6 $1.53
10/31/202234,300 shares $111,475.00 +0.3%2.0%0.8 $3.25
10/15/202234,200 shares $110,466.00 -0.9%2.0%2 $3.23
9/30/202234,500 shares $110,055.00 -7.0%2.0%1.7 $3.19
9/15/202237,100 shares $139,867.00 -13.3%2.2%1.3 $3.77
8/31/202242,800 shares $156,648.00 -11.0%2.5%1.4 $3.66
8/15/202248,100 shares $198,653.00 -7.5%2.8%1.4 $4.13
7/31/202252,000 shares $185,120.00 -2.1%3.0%1.4 $3.56
7/15/202253,100 shares $221,427.00 -13.4%3.1%1.3 $4.17
6/30/202261,300 shares $237,231.00 -31.1%3.6%0.9 $3.87
6/15/202288,900 shares $321,818.00 +8.2%5.2%1.3 $3.62
5/31/202282,200 shares $293,454.00 -17.8%N/A1.2 $3.57
5/15/2022100,000 shares $304,000.00 +47.9%N/A1.5 $3.04
4/30/202267,600 shares $198,068.00 -29.7%N/A1.1 $2.93
4/15/202296,200 shares $290,524.00 +60.1%N/A1.5 $3.02
3/31/202260,100 shares $230,784.00 -31.9%N/A1.7 $3.84
3/15/202288,300 shares $264,017.00 -19.7%N/A1.9 $2.99
2/28/2022110,000 shares $412,500.00 -0.5%N/A1.8 $3.75
2/15/2022110,600 shares $436,870.00 -16.5%N/A1.3 $3.95
1/31/2022132,400 shares $450,160.00 +7.3%N/A1.5 $3.40
1/15/2022123,400 shares $486,751.30 -15.2%N/A1.2 $3.94
12/31/2021145,500 shares $548,535.00 -15.3%N/A1.5 $3.77
12/15/2021171,800 shares $723,278.00 +100.9%N/A1.8 $4.21
11/30/202185,500 shares $378,765.00 -38.4%N/A0.9 $4.43
11/15/2021138,900 shares $647,274.00 +6.4%N/A0.1 $4.66
10/29/2021130,600 shares $619,044.00 +96.7%N/A0.1 $4.74
10/15/202166,400 shares $343,288.00 +14.5%1.0%0.1 $5.17
9/30/202158,000 shares $297,540.00 -11.0%0.8%0.1 $5.13
9/15/202165,200 shares $339,040.00 -70.5%0.9%0.1 $5.20
8/31/2021221,300 shares $1.26 million +138.5%3.2%0.2 $5.68
8/13/202192,800 shares $604,128.00 -20.1%1.3%0.5 $6.51
7/30/2021116,100 shares $743,040.00 -19.5%1.7%0.6 $6.40
7/15/2021144,300 shares $903,318.00 -28.5%2.1%0.6 $6.26
6/30/2021201,800 shares $1.35 million -15.3%2.9%0.8 $6.67
6/15/2021238,300 shares $1.53 million -12.6%3.5%0.4 $6.43
5/28/2021272,600 shares $1.55 million -0.6%4.0%0.5 $5.70
URGENT: Someone's Moving Gold Out of London... (Ad)

People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “gold analysts” have it all wrong… They tell you to invest in gold ETFs - because the popular mining ETFs will someday catch fire and close the price gap with spot gold.

Go here to learn about my Top Four picks for the coming bull mania.
5/14/2021274,200 shares $1.41 million +20.6%N/A0.4 $5.13
4/30/2021227,300 shares $1.39 million -2.5%N/A0.1 $6.10
4/15/2021233,100 shares $1.44 million +208.7%N/A0.1 $6.17
3/31/202175,500 shares $518,685.00 -39.7%N/A0 $6.87
3/15/2021125,100 shares $935,748.00 +11.9%N/A0.1 $7.48
2/26/2021111,800 shares $722,228.00 -76.4%N/A0.1 $6.46
2/12/2021474,200 shares $4.50 million +88.6%N/A0.2 $9.50
1/29/2021251,400 shares $1.03 million +3.5%N/A0.9 $4.08
1/15/2021242,900 shares $981,316.00 -3.9%N/A0.8 $4.04
12/31/2020252,800 shares $920,192.00 -5.4%N/A0.2 $3.64
12/15/2020267,200 shares $999,328.00 +10.5%N/A0.3 $3.74
11/30/2020241,800 shares $846,300.00 +6.9%N/A0.2 $3.50
11/15/2020226,100 shares $757,435.00 +92.4%N/A0.2 $3.35
10/30/2020117,500 shares $399,500.00 +2,117.0%N/A0.1 $3.40
10/15/20205,300 shares $22,154.00 -50.9%N/A0 $4.18
9/30/202010,800 shares $45,792.00 -76.9%N/A0.1 $4.24
9/15/202046,800 shares $203,580.00 -16.6%N/A0.3 $4.35
8/31/202056,100 shares $241,230.00 +516.5%N/A0.3 $4.30
8/14/20209,100 shares $45,045.00 +11.0%N/A0.1 $4.95
7/31/20208,200 shares $41,574.00 -16.3%N/A0.1 $5.07
7/15/20209,800 shares $48,412.00 -36.0%N/A0.1 $4.94
6/30/202015,300 shares $78,336.00 +62.8%N/A0.2 $5.12
6/15/20209,400 shares $49,256.00 No ChangeN/A0.1 $5.24
5/29/20209,400 shares $51,982.00 -49.7%N/A0.1 $5.53
5/15/202018,700 shares $89,386.00 +65.5%N/A0.2 $4.78
4/30/202011,300 shares $58,308.00 -41.2%N/A0.1 $5.16
4/15/202019,200 shares $111,168.00 -59.2%N/A0.2 $5.79
3/31/202047,000 shares $269,310.00 -18.0%N/A0.4 $5.73

BPTH Short Interest - Frequently Asked Questions

What is Bio-Path's current short interest?

Short interest is the volume of Bio-Path shares that have been sold short but have not yet been closed out or covered. As of February 15th, investors have sold 463,100 shares of BPTH short. 8.03% of Bio-Path's shares are currently sold short. Learn More on Bio-Path's current short interest.

Which institutional investors are shorting Bio-Path?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Bio-Path: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Bio-Path?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 8.03% of Bio-Path's floating shares are currently sold short.

Is Bio-Path's short interest increasing or decreasing?

Bio-Path saw a increase in short interest in the month of February. As of February 15th, there was short interest totaling 463,100 shares, an increase of 483.2% from the previous total of 79,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Bio-Path's float size?

Bio-Path currently has issued a total of 8,308,000 shares. Some of Bio-Path's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Bio-Path currently has a public float of 5,770,000 shares.

How does Bio-Path's short interest compare to its competitors?

8.03% of Bio-Path's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Bio-Path: NLS Pharmaceutics Ltd. (2.66%), Sonoma Pharmaceuticals, Inc. (14.21%), Ensysce Biosciences, Inc. (1.83%), Organovo Holdings, Inc. (3.31%), Kazia Therapeutics Limited (2.32%), Clearmind Medicine Inc. (6.53%), Adial Pharmaceuticals, Inc. (8.50%), Aptorum Group Limited (0.96%), Creative Medical Technology Holdings, Inc. (1.46%), Allarity Therapeutics, Inc. (14.12%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($25.81 billion), iShares 20+ Year Treasury Bond ETF ($10.38 billion), MicroStrategy Incorporated ($7.74 billion), AppLovin Co. ($6.32 billion), Apollo Global Management, Inc. ($5.97 billion), Super Micro Computer, Inc. ($4.89 billion), Charter Communications, Inc. ($4.52 billion), Capital One Financial Co. ($3.94 billion), Schlumberger Limited ($3.19 billion), and Reddit, Inc. ($3.01 billion). View all of the most shorted stocks.

What does it mean to sell short Bio-Path stock?

Short selling BPTH is an investing strategy that aims to generate trading profit from Bio-Path as its price is falling. BPTH shares are trading down $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Bio-Path?

A short squeeze for Bio-Path occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of BPTH, which in turn drives the price of the stock up even further.

How often is Bio-Path's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BPTH, twice per month. The most recent reporting period available is February, 15 2025.




This page (NASDAQ:BPTH) was last updated on 3/30/2025 by MarketBeat.com Staff
From Our Partners